Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments (VCI): a network meta‐analysis

Review of 8 RCTs (n=4373) found moderate‐high certainty evidence that donepezil 5 mg and 10 mg and galantamine have a slight beneficial effect on cognition in VCI. The size of the change is unlikely to be clinically important. The evidence for rivastigmine was less certain.

Source:

Cochrane Database of Systematic Reviews